Non-Melanoma Skin Cancers Coverage from Every Angle
Advertisement
Advertisement

Recent News

ESMO 2021: Final Results of Phase II Trial of First-Line Nivolumab in Squamous Cell Carcinoma
ESMO 2021: Extended-Dose Cemiplimab-rwlc Under Study in Squamous Cell Carcinoma
Topical Remetinostat Under Study in Basal Cell Carcinoma
Intraoperative Fluorescent Imaging Agent Under Study in Patients With Skin Cancer
Link Between Cutaneous HPV and Squamous Cell Skin Cancer?
Combination Checkpoint Antibody Treatment in Cutaneous Squamous Cell Carcinoma
Study Finds Stem Cell Markers Point to Origin and Prognosis in Merkel Cell Carcinoma
Does Lifetime Ambient UV Radiation Exposure Impact Skin Cancer Risk by Anatomic Site?
Is High Citrus Consumption Associated With Non-Melanoma Skin Cancer Risk?
Exclusive Radiotherapy: Potential Alternative to Surgery for Merkel Cell Carcinoma?
Use of Avelumab for Oligoprogression in Advanced Merkel Cell Carcinoma: Case Report
Checking Checkpoint Inhibitor Effectiveness in Immunocompromised Patients With Advanced Skin Cancer
Trends in Skin Cancers: Findings From Global Burden of Disease Study
Serial Excision: Appropriate Alternative to Mohs Micrographic Surgery for Non-Melanoma Skin Cancer?
Perioperative Use of Cemiplimab Under Study in Cutaneous Squamous Cell Carcinoma
FDA Expands Pembrolizumab Label for Locally Advanced Cutaneous Squamous Cell Carcinoma
ASCO 2021: Phase II Study of Domatinostat Plus Avelumab for Merkel Cell Carcinoma
ASCO 2021: Dutch Study of Postoperative Radiotherapy in Merkel Cell Carcinoma
ASCO 2021: Combination of HDAC Inhibitor and Pembrolizumab in Advanced Skin Cancer
ASCO 2021: Cemiplimab-rwlc and Quality of Life in Patients With Locally Advanced Skin Cancer
Are American Adults Taking Skin Cancer Seriously? Survey Findings Suggest Perhaps Not
ASCO 2021: Cetuximab After Disease Progression With Immunotherapy in Advanced Skin Cancer
ASCO 2021: Health-Related Quality of Life With Pembrolizumab for Cutaneous Squamous Cell Carcinoma
Australian Researchers Explore Immunotherapy-Related Concepts in Squamous Cell Skin Cancer
Does Citrus Juice Consumption Affect the Risk of Non-Melanoma Skin Cancer?
Decreasing Skin Cancer Incidence Through Restrictions on Indoor Tanning
Genetic Relationship between Non-Melanoma Skin Cancer and CLL
Exploring the Potential Role of Podoplanin in Cutaneous Squamous Cell Carcinoma
Antihypertensive Medications and Risk of Skin Cancer in Older Individuals
Let There Be Light: Can Blue Light Exposure With Cisplatin Treat Skin Cancer?
Topical MEK Inhibitor Under Study in Cutaneous Squamous Cell Carcinoma
High-Dose–Rate Brachytherapy for Non-Melanoma Skin Cancer
Do Local Excision Margins Influence Survival in Merkel Cell Carcinoma?
AACR 2021: Do Immune-Mediated Diseases Influence Risk of Skin Cancer?
Psoriasis and Risks of Basal and Squamous Cell Carcinomas
Long-Term Risk of Cutaneous Squamous Cell Carcinoma After Actinic Keratosis
AACR 2021: Is Pembrolizumab Effective in Treating Advanced Cutaneous Squamous Cell Carcinoma?
Can High-Frequency Ultrasound Improve Accuracy of Identifying Basal Cell Carcinoma?
Follow-up Care Strategy for Patients With Low-Risk Basal Cell Carcinoma
Australian Surveillance Program for Individuals at High Risk of Aggressive Skin Cancer
Role of Filaggrin Expression in Squamous and Basal Cell Carcinomas
Novel Vaccine Under Study in Basal Cell Carcinoma


By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.